Tivozanib (and More)
Mar 18, 2021•18 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Tivozanib's FDA approval for mRCC was a long time in the making, but what is its role?
Disappointing atezolizumab results for adjuvant treatment of bladder cancer (IMvigor-010).
Preliminary data on antibody responses to COVID-19 vaccination in cancer patients.
For the best experience, listen in Metacast app for iOS or Android